https://www.buffalo.edu/news/releases/2023/09/UB-research-semaglutide-Type-1-diabetes-insulin.html
0
0
9/6/23 at 2:55pm
Organization
University at Buffalo Reporter
Authors
Treating newly diagnosed Type 1 diabetes patients with semaglutide may drastically reduce or even eliminate their need for injected insulin.
Create an account
or login to join the discussion